CBD Isolate Drug Epidiolex Approved by FDA

By |2019-03-10T03:01:17+00:00Mar,19 8|Categories: CBD|Tags: , , , , , , , , , , |

Epidiolex, a new pharmaceutical drug containing CBD Isolate opens up a new era of cannabinoid medicine and cannabis reform. CBD Isolate Anti-Epilepsy Drug Epidiolex Approved by FDA On June 25, 2018, the United States Food & Drug Administration (FDA) approved EPIDIOLEX® - a CBD isolate-based oral solution for the treatment of seizures associated with two severe epilepsy syndromes - Lennox-Gastaut [...]

CBD Isolate Drugs Rescheduled by the FDA

By |2018-09-28T06:03:43+00:00Sep,18 28|Categories: CBD|Tags: , , , , , , , , , |

CBD Isolate Drugs Rescheduled by the FDA CBD isolate based drug Epidolex has been removed from Schedule I and placed in Schedule V which will make access to the drug much simpler for patients who can afford it. The rescheduling is a major breakthrough in the medical cannabis and hemp CBD industry because it finally recognises [...]

>